S. 1880 · 109th Congress
National Biodefense and Pandemic Preparedness Act of 2005
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
KennedySponsor9 cosponsors · 9 D
7 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
National Biodefense and Pandemic Preparedness Act of 2005 - Establishes the National BioVenture Trust as a federal government corporation to administer the BioShield Act and support the development of countermeasures. Requires the Trust to establish a Vulnerable Populations Working Group.
What it does: CRS summary · Introduced in Senate · Oct 17, 2005
National Biodefense and Pandemic Preparedness Act of 2005 - Establishes the National BioVenture Trust as a federal government corporation to administer the BioShield Act and support the development of countermeasures. Requires the Trust to establish a Vulnerable Populations Working Group.
Amends the Public Health Service Act to provide for adequate countermeasure domestic manufacturing capacity and construction of additional facilities.
Expands the definition of "security countermeasure" to include vaccines or microbicides used to treat or prevent certain diseases or viruses that may contribute to a pandemic.
Provides incentives for development and production of countermeasures.
Allows the Secretary of Health and Human Services to provide grants to support the cost of screening, research, development, testing, and initial manufacture of potential candidates for countermeasures.
Requires the Secretary, acting through the Commission of Food and Drugs, to facilitate the prompt development, review, and approval of security countermeasures.
Amends the Federal Food, Drug, and Cosmetic Act to require postmarket studies for countermeasures after an exigency requiring the use of the drug arises.
Establishes the Biodefense Injury Compensation Program to provide compensation for damages that are likely caused by the administration of a covered countermeasure.
Extends liability protection for health professionals administering small pox countermeasures to include other countermeasures.
Sets forth provisions regarding pandemic influenza preparedness plans, a buyback program for influenza vaccines, price gouging, an influenza vaccine electronic tracking system, and critical antimicrobial drugs.
Establishes the National Institute of Pathology and a Board of Regents of the Institute. Transfers to the Institute certain functions of the Armed Forces Institute of Pathology.
Requires the Secretary to establish the National Advisory Committee on Vulnerable Populations and Terrorism.
Requires the Secretary to establish a Select Agent Advisory Committee to advise on matters related to security checks for individuals handling biological agents or toxins.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: National Biodefense and Pandemic Preparedness Act of 2005
Latest action (Oct 17, 2005): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Oct 17, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.